Farmacogenes

PharmaGKB summary- very important pharmacogene information for angiotensin-converting enzyme

PharmaGKB summary - very important pharmacogene information for CYP2C19

PharmaGKB summary- very important pharmacogene information for CYP2B6

PharmaGKB summary- cytochrome P450 family 2 subfamily J polypeptide 2 - CYP2J2

PharmaGKB summary- very important pharmacogene information for PTGS2

PharmaGKB summary - very important pharmacogene information for CYP1A2

Pharmacogenomics of CYP2D6 - molecular genetics interethnic differences and clinical importance

PharmaGKB summary - very important pharmacogene information for G6PD

The role of genetics in drug dosing

PharmaGKB summary - very important pharmacogene information for CYP3A5

PharmaGKB summary- very important pharmacogene information for GSTT1

Polymorphisms of UGT1A1-6 UGT1A1-27 y UGT1A1-28 in three major ethnic groups from Malaysia

NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure

Molecular mechanisms of genetic variation and transcriptional regulation of CYP2C19

Pharmacogenetics of cytochrome P450 3A4-recent progress toward the missing heritability problem

La era de la farmacogenómica - el ejemplo del clopidogrel

Regresar al Acervo